- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 57.61M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 54.9M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 51.86M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $28K |
| Capex | Q1 2026 · Mar 31, 2025 | $119K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$5.64M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$6.71M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $35.67M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $48.72M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$4M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$6.51M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $64.09M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $69.99M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $59.35M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $78.39M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $267.91M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $292.15M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $128.52M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $137.28M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $263.91M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $285.64M |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $8.28M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $12.94M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $6.43M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $10.28M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$4.48M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$13.28M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$8.27M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$11.12M |
| Revenue | Q1 2026 · Mar 31, 2026 | $34.32M |
| Revenue | Q1 2026 · Mar 31, 2025 | $56.44M |